A client admitted with neutropenia would most likely be started on which of the following medications to promote neutrophil differentiation?
A) Epogen (epoetin)
B) Neulasta (pegfilgrastim)
C) Neurontin (gabapentin)
D) Procardia (nifedipine)

Question

Quizplus · Accepted Answer

Neulasta (pegfilgrastim) is a medication that stimulates the production and differentiation of neutrophils, which can help increase the patient's neutrophil count and prevent infections. Epogen (epoetin) is used to stimulate red blood cell production and would not be effective in treating neutropenia. Neurontin (gabapentin) is a medication used for nerve pain and seizures, and Procardia (nifedipine) is used for blood pressure control and angina, neither of which are effective for treating neutropenia.

A Client Admitted with Neutropenia Would Most Likely Be Started